Allero Therapeutics: a biopharmaceutical company developing next generation immunotherapies for immune mediated diseases
Belgium
The Problem
Abnormal immune response can cause chronic and life threatening conditions. Current therapies are injection-based, do not reinstate tolerance, but instead treat symptoms or suppress immune system with potential side effects.
The Solution
An ideal therapeutic would restore normal immune balance/tolerance, avoid global immune suppression and treat the cause of the disease,
Based on research by the founders and their collaborators the team has identified a novel specific immunotherapy approach based on antigen-specific tolerance induction. The approach defines a platform technology which is broadly applicable to a range of clinical indications with profound unmet medical need, e.g. autoimmune and allergic diseases.